Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
capecitabine (xeloda) (1 trial)
gemcitabine (gemzar) (1 trial)
COVID-19 convalescent plasma (1 trial)
Cholangiocarcinoma (Phase 4)
Klatskin Tumor (Phase 4)
Trials (2 total)
Trial APIs (3 total)